Cure HHT

The team at NPL is honored to be working with Cure HHT. Hereditary Hemorrhagic Telangiectasia (HHT) is an inherited disease that leads to malformed blood vessels and can affect multiple organs. It is often misdiagnosed, and many doctors do not understand its manifestations. The board and lead staff of Cure HHT recently convened in Chicago, and NPL facilitated sessions on board development and major gift fundraising in advance of a kickoff campaign Called to Cure—Generation to end HHT